0001555280-23-000108.txt : 20230216 0001555280-23-000108.hdr.sgml : 20230216 20230216161849 ACCESSION NUMBER: 0001555280-23-000108 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230214 FILED AS OF DATE: 20230216 DATE AS OF CHANGE: 20230216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lagano Roxanne CENTRAL INDEX KEY: 0001567878 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35797 FILM NUMBER: 23638741 MAIL ADDRESS: STREET 1: C/O ZOETIS INC. STREET 2: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zoetis Inc. CENTRAL INDEX KEY: 0001555280 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 460696167 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 973-822-7000 MAIL ADDRESS: STREET 1: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 4 1 wf-form4_167658231320285.xml FORM 4 X0306 4 2023-02-14 0 0001555280 Zoetis Inc. ZTS 0001567878 Lagano Roxanne C/O ZOETIS INC. 10 SYLVAN WAY PARSIPPANY NJ 07054 0 1 0 0 Executive Vice President Common Stock 2023-02-14 4 M 0 6984 73.24 A 33341 D Common Stock 2023-02-14 4 M 0 6026 87.51 A 39367 D Common Stock 2023-02-14 4 S 0 13010 175 D 26357 D Common Stock 795.7349 I 401(k) Stock Option 2023-02-14 4 M 0 6984 0 D Common Stock 6984.0 30585 D Stock Option 2023-02-14 4 M 0 6026 0 D Common Stock 6026.0 24559 D Stock Option 162.07 Common Stock 6542.0 6542 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 25, 2022. The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions. Represents the common stock equivalents held in the Zoetis Inc. Savings Plan, a 401(k) plan, as of December 31, 2022. Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. 6,984 options granted February 13, 2018 at an exercise price of $73.24 per option. Each option vests on the third anniversary of the date of grant. Each option expires on the tenth anniversary of the date of grant. 2,328 options granted February 13, 2018 at an exercise price of $73.24 per option; 8,036 options granted February 12, 2019 at an exercise price of $87.51 per option; 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option; and 5,377 options granted February 8, 2022 at an exercise price of $201.30 per option. 6,026 options granted on February 12, 2019 at an exercise price of $87.51 per option. 2,328 options granted February 13, 2018 at an exercise price of $73.24 per option; 2,010 options granted February 12, 2019 at an exercise price of $87.51 per option; 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option; and 5,377 options granted February 8, 2022 at an exercise price of $201.30 per option. Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan. One-third of each option will vest on the first, second and third anniversaries of the date of grant. /s/ Brenda Santuccio, as Attorney-in-Fact 2023-02-16